Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA guidances

This article was originally published in The Gray Sheet

Executive Summary

Agency's Center for Devices and Radiological Health issues "Guidance Document for Vascular Prostheses 510(k) Submissions," developed "as a special control to support reclassification from Class III to Class II for vascular graft prostheses," Nov. 26. The center simultaneously issues "Guidance for Annuloplasty Rings 510(k) Submissions," also as a special control, and "Guidance for Cardiovascular Intravascular Filter 510(k) Submissions," which supersedes the agency's Feb. 11, 1997 guidance on premarket notification for the same devices. Draft "Guidance for Resorbable Adhesion Barrier Devices for Use in Abdominal and/or Pelvic Surgery" is also available for comment on CDRH web site

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel